Compounds > methylnitrosourea
Page last updated: 2024-08-21

methylnitrosourea and medroxyprogesterone acetate

methylnitrosourea has been researched along with medroxyprogesterone acetate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoh, N; Mori, H; Morishita, S; Murase, T; Niwa, K; Tamaya, T; Tanaka, T1
Charreau, EH; Elizalde, P; Lanari, C; Molinolo, AA; Montecchia, F; Pazos, P1
Lanari, C; Molinolo, AA; Pazos, P1
Choi, MR; Christov, K; Ivancic, D; Khan, SA; Lee, O1

Other Studies

4 other study(ies) available for methylnitrosourea and medroxyprogesterone acetate

ArticleYear
Inhibitory effects of medroxyprogesterone acetate on mouse endometrial carcinogenesis.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cocarcinogenesis; Disease Models, Animal; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endometrium; Estradiol; Female; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mice, Inbred ICR; Proliferating Cell Nuclear Antigen

1995
Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice.
    Carcinogenesis, 1998, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Animals; Carcinogens; Cocarcinogenesis; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mice, Inbred BALB C

1998
Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice.
    Leukemia research, 2001, Volume: 25, Issue:2

    Topics: Animals; Female; Immunohistochemistry; Incidence; Lymphoma; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mice, Inbred BALB C

2001
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Cancer letters, 2016, 07-01, Volume: 376, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors

2016